. Author manuscript; available in PMC: 2014 May 22.

Published in final edited form as: Calif Agric (Berkeley). 2011 July-September;65(3):106–111. doi: 10.3733/ca.v065n03p106

TABLE 2.

Changes in serum oxylipins pre- and post-supplementation in IgAN patients given fish oil or corn oil placebo, and controls given fish oil^*

Oxylipin	Controls^†	IgAN patients
Oxylipin	Controls^†	Corn oil placebo	Fish oil
	——— % ———
Diols	27	0	−17
COX^‡	−4	0	0
Total oxylipins	0	0	−15

Data are percent change from pre-to postsupplementation, calculated as mean values of total oxylipins of each category for each group ((Post-Pre)/Pre) × 100.

^†

Controls = supplemented with omega-3 fatty acids from fish oil; Fish oil = immunoglobulin A nephropathy (IgAN) patients supplemented with omega-3 fatty acids from fish oil; Corn oil = IgAN patients supplemented with corn oil placebo.

^‡

COX = cyclooxygenase.